Welcome to Sequence Card of Peptide
Details of SAPdb entry with Sequence yA |
| Primary information | |
|---|---|
| SAPdb ID | 1027, |
| PMID | 18035858 |
| Peptide Name | (4-3,4-3,5)12G2-CH2-Boc-L-Tyr-L-Ala-OMe |
| Peptide sequence | YA |
| N-Terminal Modification | (4-3,4-3,5)12G2-CH2-Boc |
| C-Terminal Modification | Methoxy |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) |
| Solvent | Cyclohexane |
| Year | 2004 |
| Self assembly | Yes |
| Type of Self assembly | Helical porous columns |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| Stable | |
| Other | |
| 1.28 | |
| YA | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1028, |
| PMID | 18035858 |
| Peptide Name | (4-3,4-3,5)12G2-CH2-Moc-L-Tyr-L-Ala-OMe |
| Peptide sequence | YA |
| N-Terminal Modification | (4-3,4-3,5)12G2-CH2-Moc |
| C-Terminal Modification | Methoxy |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) |
| Solvent | Cyclohexane |
| Year | 2004 |
| Self assembly | Yes |
| Type of Self assembly | Helical porous columns |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| Stable | |
| Other | |
| 1.02 | |
| YA | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1030, |
| PMID | 18035858 |
| Peptide Name | (4-3,4-3,5)12G2-CH2-Boc-D-Tyr-D-Ala-OMe |
| Peptide sequence | ya |
| N-Terminal Modification | (4-3,4-3,5)12G2-CH2-Boc |
| C-Terminal Modification | Methoxy |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) |
| Solvent | Cyclohexane |
| Year | 2004 |
| Self assembly | Yes |
| Type of Self assembly | Helical porous columns |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| Stable | |
| Other | |
| 1.36 | |
| ya | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1031, |
| PMID | 18035858 |
| Peptide Name | (4-3,4-3,5)12G2-CH2-Boc-D-Tyr-L-Ala-OMe |
| Peptide sequence | yA |
| N-Terminal Modification | (4-3,4-3,5)12G2-CH2-Boc |
| C-Terminal Modification | Methoxy |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) |
| Solvent | Cyclohexane |
| Year | 2004 |
| Self assembly | Yes |
| Type of Self assembly | Helical porous columns |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| Stable | |
| Other | |
| 1.28 | |
| yA | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1032, |
| PMID | 18035858 |
| Peptide Name | (4-3,4-3,5)12G2-CH2-Boc-L-Tyr-D-Ala-OMe |
| Peptide sequence | Ya |
| N-Terminal Modification | (4-3,4-3,5)12G2-CH2-Boc |
| C-Terminal Modification | Methoxy |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) |
| Solvent | Cyclohexane |
| Year | 2004 |
| Self assembly | Yes |
| Type of Self assembly | Helical porous columns |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| Stable | |
| Other | |
| 1.34 | |
| Ya | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1621, |
| PMID | 24896538 |
| Peptide Name | Fmoc-YA |
| Peptide sequence | YA |
| N-Terminal Modification | Fmoc [or N-(fluorenyl-9-methoxycarbonyl)] |
| C-Terminal Modification | Free |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM) and AFM (Atomic force Microscopy) |
| Solvent | Phosphate buffer |
| Method | 10 mM Fmoc-YA solution was prepared by dissolving 5.32 mg of Fmoc-YA in 1 mL of phosphate buffer solution.Emusion formed after hand-shaking for 5 s emulsions form in vials. Gel formed in 24 hours on incubation at room temperature. |
| Conc | 10mM |
| Temperature | 8 |
| Temperature | Room temperature |
| Incubation Time | 24 hours |
| Year | 2014 |
| Self assembly | Yes |
| Type of Self assembly | Gel (consist of Fibrous network) |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| NA | |
| Hydrogel | |
| NA | |
| YA | |
| N.A. | |
| Primary information | |
| SAPdb ID | 1622, |
| PMID | 24896538 |
| Peptide Name | Fmoc-YA |
| Peptide sequence | YA |
| N-Terminal Modification | Fmoc [or N-(fluorenyl-9-methoxycarbonyl)] |
| C-Terminal Modification | Free |
| Non-Terminal Modification | None |
| Length | 2 |
| Peptide/Conjuagate | Peptide |
| Conjugate partner | None |
| Technique | Scanning Electron Microscopy (SEM) and AFM (Atomic force Microscopy) |
| Solvent | Phosphate buffer + 30mM chloroform |
| Method | 10 mM Fmoc-YA solution was prepared by dissolving 5.32 mg of Fmoc-YA in 1 mL of phosphate buffer solution. Different volumes of chloroform were added to Fmoc-YL buffer solution at 80 °C after hand-shaking for 5 s emulsions form in vials. Gel formed in 24 hours on incubation at room temperature. |
| Conc | 10mM |
| Temperature | 8 |
| Temperature | Room temperature |
| Incubation Time | 24 hours |
| Year | 2014 |
| Self assembly | Yes |
| Type of Self assembly | Gel (consist of Fibrous network) |
| Tertiary Structure (Technique) | Not Predicted), |
| Linear | |
| NA | |
| NA | |
| Hydrogel | |
| NA | |
| YA | |
| N.A. | |